« back to the search result list  
MANGANESEICSC: 0174 (November 2003)
CAS #: 7439-96-5
EC Number: 231-105-1

  ACUTE HAZARDS PREVENTION FIRE FIGHTING
FIRE & EXPLOSION Combustible.  Finely dispersed particles form explosive mixtures in air.  NO open flames.  Closed system, dust explosion-proof electrical equipment and lighting. Prevent deposition of dust.  Use dry sand, special powder.   

 PREVENT DISPERSION OF DUST! AVOID EXPOSURE OF (PREGNANT) WOMEN!  
  SYMPTOMS PREVENTION FIRST AID
Inhalation Cough.  Use local exhaust or breathing protection.  Fresh air, rest. Refer for medical attention. 
Skin   Protective gloves.  Rinse and then wash skin with water and soap. 
Eyes   Wear safety goggles or eye protection in combination with breathing protection if powder.  First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention. 
Ingestion Abdominal pain. Nausea.  Do not eat, drink, or smoke during work.  Rinse mouth. Refer for medical attention . 

SPILLAGE DISPOSAL CLASSIFICATION & LABELLING
Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Sweep spilled substance into covered containers. Carefully collect remainder. Then store and dispose of according to local regulations. 

According to UN GHS Criteria

 

Transportation
UN Classification
 

STORAGE
Separated from acids. Dry. 
PACKAGING
 
MANGANESE ICSC: 0174
PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
GREY-WHITE POWDER. 

Physical dangers
Dust explosion possible if in powder or granular form, mixed with air. 

Chemical dangers
Reacts slowly with water. Reacts more rapidly with steam and acids. This produces flammable/explosive gas (hydrogen - see ICSC 0001). This generates fire and explosion hazard. 

Formula: Mn
Atomic mass: 54.9
Boiling point: 1962°C
Melting point: 1244°C
Density: 7.47 g/cm³
Solubility in water: none 


EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. 

Effects of short-term exposure
The aerosol is irritating to the respiratory tract. 

Inhalation risk
Evaporation at 20°C is negligible; a harmful concentration of airborne particles can, however, be reached quickly when dispersed. 

Effects of long-term or repeated exposure
The substance may have effects on the lungs and central nervous system. This may result in increased susceptibility to bronchitis, pneumonitis and neurologic and neuropsychiatric disorders (manganism). Animal tests show that this substance possibly causes toxicity to human reproduction or development. 


OCCUPATIONAL EXPOSURE LIMITS
TLV: (respirable fraction): 0.02 mg/m3, as TWA.
TLV: (inhalable fraction): 0.1 mg/m3, as TWA.
TLV: A4 (not classifiable as a human carcinogen).
EU-OEL: (inhalable fraction): 0.2 mg/m3 as TWA.
EU-OEL: (respirable fraction): 0.05 mg/m3 as TWA.
MAK: (inhalable fraction): 0.2 mg/m3; (respirable fraction): 0.02 mg/m3; peak limitation category: II(8); pregnancy risk group: C 

ENVIRONMENT
This substance may be hazardous to the environment. Special attention should be given to aquatic organisms. 

NOTES
Depending on the degree of exposure, periodic medical examination is suggested.
The recommendations on this Card also apply to ferro manganese. 

ADDITIONAL INFORMATION
  EC Classification
 

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.